JP2018040799A5 - - Google Patents

Download PDF

Info

Publication number
JP2018040799A5
JP2018040799A5 JP2017171651A JP2017171651A JP2018040799A5 JP 2018040799 A5 JP2018040799 A5 JP 2018040799A5 JP 2017171651 A JP2017171651 A JP 2017171651A JP 2017171651 A JP2017171651 A JP 2017171651A JP 2018040799 A5 JP2018040799 A5 JP 2018040799A5
Authority
JP
Japan
Prior art keywords
assay result
sample
assay
lipid
measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017171651A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018040799A (ja
JP7022538B2 (ja
Filing date
Publication date
Priority claimed from EP16187839.2A external-priority patent/EP3293521B1/de
Application filed filed Critical
Publication of JP2018040799A publication Critical patent/JP2018040799A/ja
Publication of JP2018040799A5 publication Critical patent/JP2018040799A5/ja
Application granted granted Critical
Publication of JP7022538B2 publication Critical patent/JP7022538B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017171651A 2016-09-08 2017-09-07 脂質妨害の決定のための脂肪血症血漿または血清試料の調製 Active JP7022538B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16187839.2 2016-09-08
EP16187839.2A EP3293521B1 (de) 2016-09-08 2016-09-08 Herstellung lipämischer plasma- oder serumproben für die bestimmung einer lipidinterferenz

Publications (3)

Publication Number Publication Date
JP2018040799A JP2018040799A (ja) 2018-03-15
JP2018040799A5 true JP2018040799A5 (https=) 2020-09-03
JP7022538B2 JP7022538B2 (ja) 2022-02-18

Family

ID=56936286

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017171651A Active JP7022538B2 (ja) 2016-09-08 2017-09-07 脂質妨害の決定のための脂肪血症血漿または血清試料の調製

Country Status (6)

Country Link
US (1) US10488308B2 (https=)
EP (1) EP3293521B1 (https=)
JP (1) JP7022538B2 (https=)
CN (1) CN107807024B (https=)
CA (1) CA2978476C (https=)
ES (1) ES2720779T3 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115508568B (zh) * 2019-01-29 2025-08-19 美国西门子医学诊断股份有限公司 降低血红蛋白A1c测定中的英脱利匹特/脂血干扰的浊度归一化算法和方法
CN111929449A (zh) * 2020-08-28 2020-11-13 保定天岳生物工程有限公司 一种aptt检测试剂盒
US20230218814A1 (en) * 2022-01-11 2023-07-13 Fenwal, Inc. Adjustment Of Target Interface Position In A Centrifuge Based On Lipid Concentration
CN116907961A (zh) * 2023-06-27 2023-10-20 郴州市第一人民医院 一种消减脂血标本血脂干扰的方法
CN119901692B (zh) * 2023-10-28 2025-12-02 柏荣诊断产品(上海)有限公司 一种减弱脂血对透散射融合增强免疫比浊检测影响的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4977685A (https=) * 1972-11-29 1974-07-26
DE4223355A1 (de) * 1992-07-16 1994-01-20 Boehringer Mannheim Gmbh Verfahren und Reagenz zur spezifischen Bestimmung von LDL in Serumproben
JP4273311B2 (ja) * 2002-04-26 2009-06-03 株式会社シノテスト 試料中の測定対象物質の測定方法及び測定試薬
CN101398422B (zh) * 2008-10-28 2012-09-05 四川大学华西医院 高甘油三脂对血红蛋白浓度测定干扰的消除方法
US20130084592A1 (en) * 2011-10-04 2013-04-04 Siemens Healthcare Diagnostics Inc. Methods for correcting assay measurements

Similar Documents

Publication Publication Date Title
JP2018040799A5 (https=)
MA46917A (fr) Anticorps anti-met, molécules de liaison à un antigène bispécifique se liant à met, et leurs procédés d'utilisation
CL2019003114A1 (es) Anticuerpos anti–tau y métodos de uso (divisional solicitud 201703063)
EP3500594A4 (en) ANTIBODIES, BINDING FRAGMENTS AND METHOD FOR USE
MA43982A (fr) Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1
BR112018070260A2 (pt) receptores quiméricos e métodos de uso dos mesmos
WO2017120523A3 (en) Anti-pro/latent myostatin antibodies and methods of use thereof
BR112013023540A2 (pt) anticorpo, kit e método para a determinação de peptídeos amilóides
WO2014134561A3 (en) Quantification of vaccine compositions
WO2016050822A3 (en) Human-derived anti-dipeptide repeats (dprs) antibody
WO2017132562A8 (en) Antigen binding proteins that bind pd-l1
MA55868A (fr) Anticorps monoclonal anti-ctla4 ou son fragment se liant à l'antigène, composition pharmaceutique et son utilisation
BR112016030183A2 (pt) anticorpos e fragmentos de ligação ao antígeno que se ligam especificamente à proteína tau associada a microtúbulos
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
WO2015006337A3 (en) Compositions and methods for increasing protein half-life in a serum
JP2018528441A5 (https=)
MX2016001573A (es) Ensayos para timp2 con mejor rendimiento en muestras biológicas.
EA201892325A1 (ru) Композиции и способы детектирования белков клетки-хозяина
BR112016017764A2 (pt) anticorpo antidengue de amplo espectro
WO2015148609A3 (en) Immunoassays using colloidal crystals
JP2016501516A5 (https=)
WO2015143194A3 (en) Immunogenetic restriction on elicitation of antibodies
WO2011109112A3 (en) Method of detecting tau protein and tau fragments in serum
WO2018138681A9 (en) Hemagglutinin-specific antibodies and uses thereof
WO2017156038A3 (en) Immunoassay controls and the use thereof